Activation of the innate immune response in diseases such as rheumatoid arthritis and atherosclerosis leads to the production of proinflammatory cytokines that can promote collagenolysis. While a number of studies suggest that inflammation plays a major role in initiating collagen degradation, the effect of collagen and collagen-degradation fragments on the inflammatory response is not well understood. We now demonstrate that different collagen fragments can either augment or suppress IL-1β production from human peripheral-blood monocytes. These data have wide-ranging implications for how amino acid variation in collagen affects disease and suggest that collagen degradation leads to the production of peptides that can modulate inflammation.
Elliott S, Cawston T. The clinical potential of matrix metalloproteinase inhibitors in the rheumatic disorders. Drugs Aging18(2):87–99, 2001.
3.
McDonnell S, Morgan M, Lynch C. Role of matrix metalloproteinases in normal and disease processes. Biochem Soc Trans27:734–740, 1999.
4.
Celentano DC, Frishman WH. Matrix metalloproteinases and coronary artery disease: a novel therapeutic target. J Clin Pharmacol.37:991–1000, 1997.
5.
Smolen JS, Redlich K, Zwerina J, Aletaha D, Steiner G, Schett G. Proinflammatory cytokines in rheumatoid arthritis: pathogenic and therapeutic aspects. Clin Rev Allergy Immunol28:239–248, 2005.
6.
Abramson SB, Amin A. Blocking the effects of IL-1β in rheumatoid arthritis protects bone and cartilage. Rheumatology41:972–980, 2002.
7.
Young JL, Libby P, Schonbeck U. Cytokines in the pathogenesis of artherosclerosis. Thromb Haemost88:554–567, 2002.
8.
Ito A, Mukaiyama A, Itoh Y, Nagase H, Thøgersen IB, Enghild JJ, Sasaguri Y, Mori Y. Degradation of interleukin 1β by matrix metalloproteinases. J Biol Chem271:14657–14660, 1996.
9.
Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol4: 617–629, 2004.
10.
Postelthwaite AE, Kang AH. Collagen- and collagen peptide-induced chemotaxis of human blood monocytes. J Exp Med143:1299–1307, 1976.
11.
Fields GB. A model for interstitial collagen catabolism by mammalian collagenases. J Theor Biol153:585–602, 1991.
12.
Overall CM. Molecular determinants of metalloproteinase substrate specificity. Mol Biotechnol22:51–86, 2002.
13.
Vankemmelbeke M, Dekeyser PM, Hollander AP, Buttle DJ, Demester J. Characterization of helical cleavages in type II collagen generated by matrixins. Biochem J330:633–640, 1998.
14.
Eckhardt A, Mikšík I, Charvátová J, Deyl Z, Forgács E, Cserháti T. Proteomics of collagen peptides: a method to reveal minor changes in post-translationally modified collagen by HPLC and capillary electrophoresis. J Liq Chromatogr Relat Technol28:1437–1451, 2005.
15.
Persikov AV, Yujia X, Brodsky B. Equilibrium thermal transitions of collagen model peptides. Protein Sci13:893–902, 2004.
16.
Danielsen CC. Thermal stability of human-fibroblast-collagenase-cleavage products of type-I and type-III collagens. Biochem J247(3):725–729, 1987.
17.
Peluso G, Petillo O, Melone MAB, Mazzarella G, Ranieri M, Tajana GF. Modulation of cytokine production in activated human monocytes by somatostatin. Neuropeptides30:443–451, 1996.
18.
Brodsky B, Persikov A. Molecular structure of the collagen triple helix. Adv Prot Chem70:301–339, 2005.
19.
Fan P, Li M, Brodsky B, Baum J. Backbone dynamics of (ProHyp-Gly)10 and a designed collagen-like triple-helical peptide by 15N relaxation and hydrogen-exchange measurements. Biochemistry32: 13299–13309, 1993.
20.
Stultz CM. Localized unfolding of collagen explains collagenase cleavage near iminopoor sites. J Mol Biol319:997–1003, 2002.
21.
Bermudez LE, Wu M, Young LS. Effect of stress-related hormones on macrophage receptors and response to tumor necrosis factor. Lymphokine Res9:137–145, 1990.
22.
Elsaid KA, Jay GD, Chichester CO. Detection of collagen type II and proteoglycans in the synovial fluids of patients diagnosed with non-infectious knee joint synovitis indicates early damage to the articular cartilage matrix. Osteoarthr Cartil11:673–680, 2003.
23.
Elsaid KA, Jay GD, Warman ML, Rhee DK, Chichester CO. Association of articular cartilage degradation and loss of boundary-lubricating ability of synovial fluid following injury and inflammatory arthritis. Arthritis Rheum52:1746–1755, 2005.
24.
Heumann D, Roger T. Initial responses to endotoxins and Gram-negative bacteria. Clinica Chimica Acta323:59–72, 2002.
